The researchers found that a two or more years’ supply of PPIs and a two or more years’ supply of H2RAs are associated with an increased risk for B12 deficiency. The researchers concluded that risks and benefits of these medications should be weighed before use.
The study’s authors include Douglas A. Corley, MD, PhD; Wei Zhao, MPH; Jennifer L. Schneider, MPH; and Jameson R. Lam, MPH.
More Articles on Gastroenterology:
ASGE Recognizes 6 Endoscopy Centers for Safety & Quality
The Changing Healthcare Environment & Gastroenterologists: Q&A With Dr. Edwin Levine
Long Island Digestive Disease Consultants Selects PriorityOne Group for IT
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.